Gapping up
In reaction to strong earnings/guidance:
- PHR +18.2%, SNBR +16.8%, HLX +16.8%, PLXS +9.5%, LVS +9.2%, RS +6.7%, CAR +5.4% (provides preliminary Q1 results; gives update on April trends), PTEN +5.2%, BX +4.7%, GTLS +4.3%, HUD +4.2%, AA +3.8%, CDE +3.5%, WST +2.9%, POOL +2.8%, FNF +2.4%, SUI +2.3%, ORLY +1.9%, CSX +1.8%, PHM +1.8%, LLY +1.4%, TSCO +1.3%, ALLE +1%
Other news:
- AVXL +13.6% (announces publication of clinical data for ANAVEX2-73 in Alzheimer's disease)
- DVAX +11.1% (announces collaboration to advance COVID-19 vaccine development)
- FLR +9.9% (selected for 8-yr position on Air Force Contract Augmentation Program V)
- TTEK +5.6% (awarded $90 mln contract by US Air Force)
- QDEL +1.8% (has applied for an Emergency Use Authorization for the Lyra Direct SARS-CoV-2 Assay)
- GOOD +1.8% (provides update related to COVID-19)
- OBSV +1.8% (announces publication of abstracts from Phase 2b EDELWEISS trial)
Analyst comments:
- NLS +8.7% (upgraded to Buy from Hold at SunTrust)
- ATRA +2% (upgraded to Buy from Neutral at Citigroup)
- CMG +1.9% (upgraded to Market Perform from Underperform at BMO Capital Markets)
- CHUY +1.6% (upgraded to Market Perform from Underperform at BMO Capital Markets)